Diskus is superior to Elpenhaler with regard to ease of use, preference and satisfaction.
ID
Bron
Verkorte titel
Aandoening
asthma
astma
COPD
chronische bronchitis
longemfyseem
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Percentage of patients doing at least 1 critical error using each device after reading the insert.
Achtergrond van het onderzoek
Study evaluating ease of use, preference and satisfaction of two different Fluticason/salmeterol inhalers in asthma and COPD patients.
Primary Objective:
To compare the percentage of COPD and asthma patients correctly (all critical items correct) using the Accuhaler/Diskus vs Elpenhaler inhaler devices after reading the package insert.
Secondary Objectives:
1. To compare patient’s overall satisfaction with each device;
2. To compare the number of instructions needed for correct use of each device;
3. To compare the patient’s overall preference for a device.
Study Design:
Randomized cross-over multinational and multicentre design with one measurement moment; both devices will contain only placebo.
Study Population:
A total of 110 subjects, 55 subjects per sequence, will be randomized.
Evaluations:
Correct use, patient’s preference and satisfaction will be evaluated using the inhaler devices with placebo.
Doel van het onderzoek
Diskus is superior to Elpenhaler with regard to ease of use, preference and satisfaction.
Onderzoeksopzet
The study consists of 1 visit.
Onderzoeksproduct en/of interventie
Randomized cross-over multicentre design with one measurement moment; both devices will contain only placebo.
The subjects will be randomly distributed into 2 groups, determining the sequence of use of each inhaler: patients in Group A will use Accuhaler/Diskus device first and secondly the Elpenhaler. Patients in Group B will use Elpenhaler first followed by Accuhaler/Diskus.
The study consists of 1 visit. First, the patient will be asked to read the written package insert of the first device according to the sequence of Group A or B, which is followed by a first attempt. If any mistake in inhalation is made patients will be instructed by a trainer in the device (up to 4 attempts).
Publiek
P.O. Box 50000
J. Palen, van der
Enschede 7500 KA
The Netherlands
+31 (0)53 4872023
Wetenschappelijk
P.O. Box 50000
J. Palen, van der
Enschede 7500 KA
The Netherlands
+31 (0)53 4872023
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Adult male or female patients aged > 40 with stable COPD or asthma;
2. Patients have to be naïve to the study inhalers, Accuhaler/Diskus and Elpenhaler for at least 1 year;
3. Patients agreeing on participating and signing the Informed Consent Form.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Patients currently participating in another randomised clinical trial;
2. Patients with body malformations or diseases affecting coordination and/or motor system;
3. Patients unable to read product package instructions and answer patient reported questionnaires.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL2847 |
NTR-old | NTR2989 |
Ander register | METC / CCMO : P11-26 / NL37382.044.11; |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |